Skip to main content

Table 3 Incidence of patients with cancer associated anaemia in Greece and categorization per type of anaemia treatment

From: Budget impact analysis on erythropoiesis–stimulating agents use for the management of chemotherapy-induced anaemia in Greece

Type of cancer

% Of patients with cancer associated anaemia on treatment1

Newly diagnosed cancer patients in Greece2

Number of Greek patients with cancer associated anaemia or treatment1,2

Number of Greek patients on treatment with ESAs (17,4%)1,2

Number of Greek patients on treatment with transfusion (14,9%)1,2

Number of Greek patients on treatment with iron only (6,5%)1,2

Number of Greek patients under no treatment (61,2%)1,2

Breast

26.2

4.349

1.139

198

170

74

697

Lung

47.7

6.667

3.180

553

474

207

1.946

Gl-Colon

33

5.062

1.670

291

249

109

1.022

Head & Neck

46.1

1.100

507

88

76

33

310

Gynaecological

42.7

2.026

865

151

129

56

529

Lymphoma/myeloma

47.4

1.388

658

114

98

43

403

Leukaemia

53.3

1.512

806

140

120

52

493

Urogenital

43

5.610

2.412

420

359

157

1.476

Other

36.5

9.375

3.422

595

510

222

2.094

Total

375.9

37.089

14.660

2.551

2.184

953

8.972

  1. Sources: 1(Ludwig et al. 2004), 2WHO-Globocan 2008.